KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Depreciation and Depletion: 2022-2025

Historic Depreciation and Depletion for Twist Bioscience (TWST) over the last 3 years, with Sep 2025 value amounting to $5.7 million.

  • Twist Bioscience's Depreciation and Depletion fell 10.94% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year decrease of 12.09%. This contributed to the annual value of $23.8 million for FY2025, which is 12.82% down from last year.
  • Per Twist Bioscience's latest filing, its Depreciation and Depletion stood at $5.7 million for Q3 2025, which was down 1.72% from $5.8 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Depreciation and Depletion ranged from a high of $7.3 million in Q3 2023 and a low of $3.9 million during Q4 2022.
  • Over the past 3 years, Twist Bioscience's median Depreciation and Depletion value was $6.4 million (recorded in 2025), while the average stood at $6.5 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first surged by 76.92% in 2023, then fell by 17.14% in 2025.
  • Over the past 4 years, Twist Bioscience's Depreciation and Depletion (Quarterly) stood at $3.9 million in 2022, then spiked by 76.92% to $6.9 million in 2023, then fell by 11.59% to $6.1 million in 2024, then fell by 10.94% to $5.7 million in 2025.
  • Its last three reported values are $5.7 million in Q3 2025, $5.8 million for Q2 2025, and $6.4 million during Q1 2025.